Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nucleic Acid Therapeutics for Liver Fibrosis Posted on 15th March 202112th March 2021
Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine Posted on 20th January 202120th January 2021
Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics Posted on 13th January 202120th January 2021
